rLj-RGD3 Suppresses the Growth of HeyA8 Cells in Nude Mice

In the previous study, rLj-RGD3, a recombinant toxin protein which contains three RGD motifs, was reported to not only inhibit the proliferation of an ovarian cancer cell line, HeyA8 cells, by inducing apoptosis, but also block their adhesion, migration and invasion processes. However, whether rLj-R...

Full description

Bibliographic Details
Main Authors: Yuanyuan Zheng, Li Lv, Longda Yi, Rui Wu, Rong Xiao, Jihong Wang
Format: Article
Language:English
Published: MDPI AG 2017-12-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/22/12/2234
_version_ 1828164612077387776
author Yuanyuan Zheng
Li Lv
Longda Yi
Rui Wu
Rong Xiao
Jihong Wang
author_facet Yuanyuan Zheng
Li Lv
Longda Yi
Rui Wu
Rong Xiao
Jihong Wang
author_sort Yuanyuan Zheng
collection DOAJ
description In the previous study, rLj-RGD3, a recombinant toxin protein which contains three RGD motifs, was reported to not only inhibit the proliferation of an ovarian cancer cell line, HeyA8 cells, by inducing apoptosis, but also block their adhesion, migration and invasion processes. However, whether rLj-RGD3 could also suppress the tumor growth in HeyA8 xenografted mice has not been reported yet. In the present study, rLj-RGD3 was intraperitoneally injected in the nude mice bearing HeyA8 tumors. Compared with the control group (normal saline), rLj-RGD3 inhibited the tumor growth significantly in the HeyA8 xenografted mice in a dose-dependent manner without affecting their body weights. Based on the H&E, Hoechst 33258 and TUNEL staining assays, as well as western blot analysis, rLj-RGD3 reduced the weight and volume of the solid tumors, probably by disturbing the tissue structure, inducing apoptosis and suppressing the FAK/PI3K/AKT pathway. Most importantly, rLj-RGD3 was found to prolong the survival days of the ovarian tumor xenografted mice, which suggested rLj-RGD3 might act as an effective and safe drug to treat ovarian cancer patients.
first_indexed 2024-04-12T01:30:27Z
format Article
id doaj.art-291b6210738d4b76a57327ec125e097f
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-04-12T01:30:27Z
publishDate 2017-12-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-291b6210738d4b76a57327ec125e097f2022-12-22T03:53:31ZengMDPI AGMolecules1420-30492017-12-012212223410.3390/molecules22122234molecules22122234rLj-RGD3 Suppresses the Growth of HeyA8 Cells in Nude MiceYuanyuan Zheng0Li Lv1Longda Yi2Rui Wu3Rong Xiao4Jihong Wang5School of Life Sciences, Liaoning Normal University, Dalian 116081, ChinaDepartment of Pharmacology, Dalian Medical University, Dalian 116044, ChinaSchool of Life Sciences, Liaoning Normal University, Dalian 116081, ChinaSchool of Life Sciences, Liaoning Normal University, Dalian 116081, ChinaSchool of Life Sciences, Liaoning Normal University, Dalian 116081, ChinaSchool of Life Sciences, Liaoning Normal University, Dalian 116081, ChinaIn the previous study, rLj-RGD3, a recombinant toxin protein which contains three RGD motifs, was reported to not only inhibit the proliferation of an ovarian cancer cell line, HeyA8 cells, by inducing apoptosis, but also block their adhesion, migration and invasion processes. However, whether rLj-RGD3 could also suppress the tumor growth in HeyA8 xenografted mice has not been reported yet. In the present study, rLj-RGD3 was intraperitoneally injected in the nude mice bearing HeyA8 tumors. Compared with the control group (normal saline), rLj-RGD3 inhibited the tumor growth significantly in the HeyA8 xenografted mice in a dose-dependent manner without affecting their body weights. Based on the H&E, Hoechst 33258 and TUNEL staining assays, as well as western blot analysis, rLj-RGD3 reduced the weight and volume of the solid tumors, probably by disturbing the tissue structure, inducing apoptosis and suppressing the FAK/PI3K/AKT pathway. Most importantly, rLj-RGD3 was found to prolong the survival days of the ovarian tumor xenografted mice, which suggested rLj-RGD3 might act as an effective and safe drug to treat ovarian cancer patients.https://www.mdpi.com/1420-3049/22/12/2234rLj-RGD3HeyA8 cellsnude micePI3KAKT
spellingShingle Yuanyuan Zheng
Li Lv
Longda Yi
Rui Wu
Rong Xiao
Jihong Wang
rLj-RGD3 Suppresses the Growth of HeyA8 Cells in Nude Mice
Molecules
rLj-RGD3
HeyA8 cells
nude mice
PI3K
AKT
title rLj-RGD3 Suppresses the Growth of HeyA8 Cells in Nude Mice
title_full rLj-RGD3 Suppresses the Growth of HeyA8 Cells in Nude Mice
title_fullStr rLj-RGD3 Suppresses the Growth of HeyA8 Cells in Nude Mice
title_full_unstemmed rLj-RGD3 Suppresses the Growth of HeyA8 Cells in Nude Mice
title_short rLj-RGD3 Suppresses the Growth of HeyA8 Cells in Nude Mice
title_sort rlj rgd3 suppresses the growth of heya8 cells in nude mice
topic rLj-RGD3
HeyA8 cells
nude mice
PI3K
AKT
url https://www.mdpi.com/1420-3049/22/12/2234
work_keys_str_mv AT yuanyuanzheng rljrgd3suppressesthegrowthofheya8cellsinnudemice
AT lilv rljrgd3suppressesthegrowthofheya8cellsinnudemice
AT longdayi rljrgd3suppressesthegrowthofheya8cellsinnudemice
AT ruiwu rljrgd3suppressesthegrowthofheya8cellsinnudemice
AT rongxiao rljrgd3suppressesthegrowthofheya8cellsinnudemice
AT jihongwang rljrgd3suppressesthegrowthofheya8cellsinnudemice